Skip to main content

Table 1 Baseline patient characteristics and demographic data

From: The average gonadotrophin dosage per follicle is predictive of ovarian response and cumulative live birth chances after in vitro fertilization: a retrospective cohort study

N

Group A

Group B

Group C

P

110

110

110

Duration of infertility (years)

2.78ā€‰Ā±ā€‰1.99

2.82ā€‰Ā±ā€‰2.13

2.70ā€‰Ā±ā€‰1.75

0.89

Age (years)

30.83ā€‰Ā±ā€‰3.06

31.35ā€‰Ā±ā€‰3.63

32.26ā€‰Ā±ā€‰3.09

ā€‰<ā€‰0.01

Basal FSH (IU/L)

6.59ā€‰Ā±ā€‰2.06

6.75ā€‰Ā±ā€‰1.93

7.41ā€‰Ā±ā€‰2.06

ā€‰<ā€‰0.01

Basal LH (IU/L)

4.72ā€‰Ā±ā€‰2.05

4.44ā€‰Ā±ā€‰1.72

4.44ā€‰Ā±ā€‰1.78

0.44

Basal E2 (pg/ml)

46.04ā€‰Ā±ā€‰16.27

46.53ā€‰Ā±ā€‰14.24

43.89ā€‰Ā±ā€‰14.89

0.39

Basal P (ng/ml)

0.38ā€‰Ā±ā€‰0.20

0.38ā€‰Ā±ā€‰0.23

0.37ā€‰Ā±ā€‰0.23

0.92

AFC

18.97ā€‰Ā±ā€‰5.37

16.11ā€‰Ā±ā€‰3.88

12.23ā€‰Ā±ā€‰4.16

ā€‰<ā€‰0.01

BMI (kg/m2)

22.26ā€‰Ā±ā€‰2.79

22.56ā€‰Ā±ā€‰3.19

22.30ā€‰Ā±ā€‰3.35

0.74

Diagnosis

Ā Ā Ā 

0.25

Ā Primary infertility

74 (67.27%)

82 (74.55%)

71 (64.55%)

Ā 

Ā Secondary infertility

36 (32.73%)

28 (25.45%)

39 (35.45%)

Ā 

Indications

Ā Ā Ā 

0.69

Ā Tubal factor

70 (63.64%)

73 (66.36%)

70 (63.64%)

Ā 

Ā Endometriosis

0 (0.00%)

1 (0.91%)

2 (1.82%)

Ā 

Ā Unexplained infertility

23 (20.91%)

26 (23.64%)

25 (22.73%)

Ā 

Ā Male factor

11 (10.00%)

5 (4.55%)

10 (9.09%)

Ā 

Ā Others

6 (5.45%)

5 (4.55%)

3 (2.73%)

Ā 
  1. FSH follicle stimulating hormone, LH luteinizing hormone, E2 estradiol, AFC antral follicle count, BMI body mass index, Group A below the 33rd percentile, Group B between 33rd and 67th percentiles, Group C above the 67th percentile